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Epidermodysplasia-verruciformis-associated human
papillomavirus DNA has been demonstrated in squa-
mous cell carcinomas and plucked hair from
immunocompetent patients and renal transplant
recipients. This study investigated the association
between infection with epidermodysplasia-verruci-
formis-associated human papillomavirus, identi®ed
by the detection of viral DNA in plucked eyebrow
hairs, and solar keratoses. These lesions are strongly
predictive of squamous cell carcinoma. In a cross-
sectional study 518 individuals were enrolled from a
randomly selected sample of a subtropical Australian
community. Epidermodysplasia-verruciformis-asso-
ciated human papillomavirus DNA in eyebrow hair
was detected using a nested polymerase chain reac-
tion speci®c for epidermodysplasia-verruciformis-
associated human papillomavirus types. Epidermo-
dysplasia-verruciformis-associated human papilloma-
virus DNA was present in 121 (49%) of 245 men and
116 (44%) of 262 women. There was a strongly
signi®cant increase in epidermodysplasia-verrucifor-
mis-associated human papillomavirus infection with
age (p < 0.00001), with prevalences of 29% in the
25±39 y age group, 42% at 40±59 y and 65% in the
60±79 y age group. Among men there was a strong
association between epidermodysplasia-verrucifor-
mis-associated human papillomavirus and solar kera-
toses with an odds ratio, adjusted for age, skin color,
and occupational sun exposure, of 3.40 (95% con®-
dence interval, 1.77±6.53). No such association was
found among women [odds ratio 1.03 (95% con®-
dence interval 0.59±1.77, after adjustment for the
same factors)]. Differences in occupational sun expos-
ure and smoking histories could not explain these
apparently different associations between epidermo-
dysplasia-verruciformis-associated human papilloma-
virus infection and solar keratoses in men and
women. In conclusion, epidermodysplasia-verrucifor-
mis-associated human papillomavirus infection is
associated with solar keratoses in men suggesting that
epidermodysplasia-verruciformis-associated human
papillomavirus infection, in conjunction with sex spe-
ci®c factors (like androgens), may be involved in neo-
plastic changes of keratinocytes. Key words:
epidemiology, human papillomavirus, nested polymerase
chain reaction, skin cancer. J Invest Dermatol 117:1108±
1112, 2001
C
utaneous squamous cell carcinomas and basal cell
carcinomas, together called nonmelanoma skin
cancers, are the most common malignant tumors
among white populations (Harvey et al, 1989;
Goldberg, 1996; Marks, 1996).
Solar keratoses are benign skin tumors predominantly found on
the face, backs of hands, and forearms, sites that are chronically
exposed to the sun (Frost and Green, 1994). On rare occasions solar
keratoses are precursors of squamous cell carcinoma and they share
the same risk factors (Frost and Green, 1994; Frost et al, 1998).
Exposure to sunlight is generally considered to be the most
important environmental risk factor for both solar keratoses and
cutaneous squamous cell carcinoma (Brash et al, 1991; Marks,
1996).
The high prevalence of human papillomavirus (HPV) DNA
detected in solar keratoses and squamous cell carcinomas of
immunosuppressed patients suggests a potential role for HPV
infection in the etiology of these lesions (Berkhout et al, 1995;
Shamanin et al, 1996; P®ster and ter Schegget, 1997). HPV are
small double-stranded DNA viruses found in a wide variety of
proliferative lesions of epithelial origin. The earliest evidence for
the involvement of speci®c HPV types in human skin cancer
originated from studies in patients suffering from the rare hereditary
disease epidermodysplasia verruciformis (EV) (Orth et al, 1980).
These HPV types and phylogenetically related types are commonly
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referred to as EV±HPV types and include HPV 5, 8, 9, 12, 14, 15,
17, 19±25, 36±38, and 47.
As well as being detected in solar keratoses and squamous cell
carcinoma, EV±HPV DNA has also been found in plucked hair
from both immunosuppressed and immunocompetent persons
(Boxman et al, 1997), in skin scrapings and biopsies from psoriatic
patients (Favre et al, 1998; Weissenborn et al, 1999); and from
patients with bullous disease (Favre et al, 2000). These ®ndings
indicate that EV±HPV are seen not only in certain groups of skin
cancer patients, but are widely distributed among the general
population. To date, the role of EV±HPV in the pathogenesis of
solar keratoses and squamous cell carcinoma and also in psoriasis is
unclear.
Recently, we successfully described a noninvasive technique,
plucking hairs, to obtain biologic samples from all individuals (cases
and controls) in a nested case±control study in order to determine
their EV±HPV status. Recently, we detected the same EV±HPV
types in multiple lesions from the same individual collected over
time (Berkhout et al, 2000) and in hair samples from different body
sites collected at the same time point (Boxman et al, 1997). This
suggests that viral DNA isolated from hairs might be a marker of
HPV infections elsewhere on the body. As squamous cell
carcinoma and solar keratoses commonly occur on the face,
eyebrow hairs were chosen to identify those individuals infected
with EV±HPV. Participants were drawn from a much larger
community study of skin cancer in Nambour, Queensland
(Boxman et al, 2000). A nonsigni®cant negative association
between the presence of EV±HPV DNA in eyebrow hair and
basal cell carcinoma was found and a nonsigni®cant positive
association with squamous cell carcinoma, the estimated relative
risk of developing squamous cell carcinoma among HPV-infected
individuals being 2.00 (95% con®dence interval 0.50±8.00). Given
the shortcomings of a previous study due to limited numbers of
cases with squamous cell carcinomas (n = 25), we decided to
investigate the association between the presence of EV±HPV DNA
in eyebrow hair and the more prevalent solar keratoses, in a larger
cross-sectional study. The purpose of this study was to establish the
prevalence of EV±HPV DNA in eyebrow hair, to examine factors
that may be associated with EV±HPV infection, and to address the
question of whether EV±HPV infection is associated with the
presence of solar keratoses.
MATERIALS AND METHODS
Study population In 1986, 2095 residents of the township of
Nambour in Queensland, Australia, who were randomly selected from
the electoral roll (enrollment is compulsory) attended a skin cancer
survey (Green et al, 1988). In 1992, 1626 of these participants agreed to
be part of a skin cancer prevention trial involving randomization to
sunscreen and/or b-carotene (Green et al, 1994, 1999). Half of the 1250
participants attending the 1996 skin examinations were invited to
participate in the present cross-sectional study and 518 persons took part
with their informed consent. All received whole-body skin examinations
by experienced dermatologists in 1992, 1994, and 1996.
Table I. Characteristics of persons with and without solar keratoses
Persons without
solar keratosesa
n (%)
Persons with
solar keratosesa
n (%)
Odds ratio
(95% con®dence
interval)
Numberb 231 276
Age categorized
25±39 67 (29.0) 22 (8.0) 1
40±59 128 (55.4) 135 (48.9) 3.21 (1.82; 5.71)
60±79 36 (15.6) 119 (43.1) 10.07 (5.25; 19.45)
Sex
Female 140 (60.6) 122 (44.2) 1
Male 91 (39.4) 154 (55.8) 1.94 (1.34; 2.81)
Tanning ability
Tan only 29 (12.6) 24 (8.7) 1
Burn then tan 169 (73.2) 197 (71.6) 1.41 (0.76; 2.61)
Always burn 33 (14.3) 54 (19.6) 1.98 (0.93; 4.28)
Skin color
Olive/brown 31 (13.4) 14 (5.1) 1
Medium 102 (44.1) 102 (37.1) 2.21 (1.06; 4.67)
Fair 98 (42.4) 159 (57.8) 3.59 (1.74; 7.50)
Occupational sun exposure
Mainly indoors 119 (51.5) 94 (34.2) 1
In and outdoors 76 (32.9) 109 (39.6) 1.82 (1.20; 2.76)
Mainly outdoors 36 (15.6) 72 (26.2) 2.53 (1.52; 4.23)
Smoking
Nonsmokers 136 (59.4) 151 (55.3) 1
Ex-smokers 66 (28.8) 94 (34.4) 1.28 (0.85; 1.93)
Current smokers 27 (11.8) 28 (10.3) 0.93 (0.50; 1.73)
Skin cancerc
No skin cancer 187 (80.9) 137 (49.6) d
SCC only 0 15 (5.4)
SCC + BCC 0 9 (3.3)
BCC only 15 (6.5) 54 (19.6)
Not characterized 29 (12.6) 61 (22.1)
EV±HPV in eyebrow hair
Negative 148 (64.1) 122 (44.2) 1
Positive 83 (35.9) 154 (55.8) 2.25 (1.55; 3.28)
aMean (6 SD) age in years of (i) persons without solar keratoses: 47.4 (6 11.4), and (ii) persons with solar keratoses: 57.8 (6 11.8). Difference: 10.4 y (8.37; 12.43).
bNumbers do not always add to the total due to missing information.
cSCC, squamous cell carcinoma; BCC, basal cell carcinoma.
dOdds ratios were not calculated because of blank values in some of the groups.
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Data collection At the 1996 skin examination, dermatologists counted
and mapped the positions of all solar keratoses present on 13 body sites.
Those with one or more solar keratoses at any site were de®ned as
having prevalent solar keratoses. As well, about eight to 10 hairs were
plucked from eyebrows by one of the investigators or a trained assistant
using a disposable pair of tweezers and gloves for each individual. Only
hairs that contained hair follicles were collected and samples were stored
at ±70°C until analysis.
Standard questionnaires were used to obtain data on known or
suspected risk factors for solar keratoses, including skin color, hair color,
eye color, tanning ability, occupational sun exposure at baseline, lifetime
and recent sunburn histories and smoking.
EV±HPV analysis Hair samples were lyzed in L6 buffer for 1 h. One
portion of the buffer was supplemented with diatoms (Boom et al, 1990)
and incubated for a further hour. DNA was isolated according to a
method described in Boom et al (1990). The remaining portion of L6
buffer was stored at ± 70°C. A nested polymerase chain reaction (PCR)
method was used to detect EV±HPV DNA. The degenerate primers of
the ®rst PCR (CP62/CP70a) (Berkhout et al, 1995; Boxman et al, 1997)
and nested PCR (CP65/CP69a) (Berkhout et al, 1995; Boxman et al,
1997) were located in the L1 open reading frame and designed to detect
the subgroup of known EV±HPV types. Eight to 10% of the extractable
DNA was used as input to the ®rst step PCR. All PCR reactions were
performed as described by Boxman et al (1997). A negative control
(water) was included between each set of two DNA samples and
processed in the same way as the hair samples throughout DNA
preparation and both PCR steps. No negative controls were positive for
EV±HPV. To determine the ef®cacy of the nested PCR, 10-fold
dilutions of DNA of a plasmid containing HPV15 were used as positive
controls. The detection limit for this plasmid was 0.1 fg, representing
about 10 molecules of HPV DNA.
HPV typing of 89 positive PCR samples con®rmed that only EV±
HPV DNA was ampli®ed by the PCR used (Boxman et al, 2000). In
addition, because none of the negative controls were positive in the
PCR, no further sequence analyses were performed in our study.
Statistical analysis Calculations were performed with the statistical
software package of the SAS Institute Inc. (Cary, NC). The data were
analyzed using Student's t test and the chi-square test. Odds ratios were
estimated from logistic regression. Multivariate logistic regression analysis
was used to adjust for confounders. Factors that were considered were
age, sex, tanning ability, skin color, occupational sun exposure, smoking,
and trial design factors [daily sunscreen application (vs discretionary
sunscreen application) and of b-carotene (vs placebo)] (Green et al,
1999).
In addition, Mantel±Haenszel weighted odds ratios were calculated to
adjust for age groups by using Epi-Info (version 6.04b, Centers for
Disease Control & Prevention, U.S.A. and World Health Organization,
Geneva, Switzerland).
RESULTS
Among the 518 individuals who agreed to participate there were
®ve whose samples were lost during transport or storage, and of the
remaining 513 individuals, the presence of solar keratoses was
scored in 507 individuals. Analyses were restricted to these 507, of
whom 245 (48%) were male. The mean age of men taking part was
53.0 y, and of women, 53.1 y.
Characteristics of persons with and without solar keratoses are
presented in Table I. Persons with solar keratoses were signi®-
cantly older, were more often male, had fairer skin, less often had
an outdoor occupation, and had more frequently developed skin
Table II. Characteristics of persons with and without HPV infection
Persons without HPV
infectiona n (%)
Persons with HPV
infectiona n (%)
Odds ratio
(95% con®dence
interval)
Numberb 270 237
Age categorized
25±39 63 (23.3) 26 (11.0) 1
40±59 153 (56.7) 110 (46.4) 1.74 (1.01; 3.03)
60±79 54 (20.0) 101 (42.6) 4.53 (2.49; 8.30)
Sex
Female 146 (54.1) 116 (48.9) 1
Male 124 (45.9) 121 (51.1) 1.23 (0.85; 1.77)
Tanning ability
Tan only 26 (9.7) 27 (11.4) 1
Burn then tan 197 (73.2) 169 (71.3) 0.83 (0.45; 1.53)
Always burn 46 (17.1) 41 (17.3) 0.86 (0.41; 1.80)
Skin color
Olive/brown 23 (8.6) 22 (9.3) 1
Medium 104 (38.7) 100 (42.2) 1.01 (0.50; 2.01)
Fair 142 (52.8) 115 (48.5) 0.85 (0.43; 1.67)
Occupational sun exposure
Mainly indoors 132 (49.1) 81 (34.2) 1
In and outdoors 88 (32.7) 97 (40.9) 1.80 (1.18; 2.73)
Mainly outdoors 49 (18.2) 59 (24.9) 1.96 (1.20; 3.22)
Smoking
Nonsmokers 157 (58.6) 130 (66.5) 1
Ex-smokers 80 (29.8) 80 (34.2) 1.21 (0.80; 1.81)
Current smokers 31 (11.8) 24 (10.3) 0.93 (0.50; 1.74)
Skin cancerc
No skin cancer 183 (67.8) 141 (59.5) 1
SCC only 3 (1.1) 12 (5.1) 5.19 (1.33; 23.64)
SCC + BCC 5 (1.9) 4 (1.7) 1.04 (0.23; 4.55)
BCC only 28 (10.4) 41 (17.3) 1.90 (1.09; 3.33)
Not characterized 51 (18.9) 39 (16.5) 0.99 (0.60; 1.63)
Solar keratoses
Absent 148 (54.8) 83 (35.0) 1
Present 122 (45.2) 154 (65.0) 2.25 (1.55; 3.28)
aMean age (6 SD) in years of (i) persons without HPV infection: 49.2 (6 11.4) and (ii) persons wth HPV infection: 57.5 (6 12.7). Difference: 8.3 (6.20; 10.40) years.
bNumbers do not always add to the total due to missing information.
cSCC, squamous cell carcinoma; BCC, basal cell carcinoma.
1110 BOXMAN ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
cancer. There was a strong association between the presence of
solar keratoses and the presence of EV±HPV in plucked eyebrow
hair (p < 0.00001).
Characteristics of persons with and without EV±HPV infection
are presented in Table II. The overall prevalence of EV±HPV
infection was 49.4% (121 of 245) for men and 44.3% (116 of 262)
for women. There was a strongly signi®cant increase in EV±HPV
infection with age (p < 0.00001), with prevalences of 29% in the
25±39 y age group, 42% at 40±59 y, and 65% in the 60±79 y age
group. Occupational sun exposure was signi®cantly associated and
sex, tanning ability, skin color, and smoking were not statistically
signi®cantly associated with EV±HPV infection (see Table II).
From the outset our analyses showed that there was a strong
association between EV±HPV infection and solar keratoses among
men but no such association among women, and thus the
association between HPV infection and solar keratoses have been
presented separately for men and women. To calculate the
association between HPV infection and solar keratoses, we adjusted
for age, skin color, and occupational sun exposure. No adjustments
were made for past or contemporary skin cancer history, because
solar keratoses are potential precursors of squamous cell carcinoma.
Among men there was a strong association between presence of
EV±HPV in plucked eyebrow hair and presence of solar keratoses
with a crude odds ratio of 4.03 (95% con®dence interval 2.22±
7.33). The pooled odds ratio adjusted for age groups by use of the
Mantel±Haenszel test was 2.65 (95% con®dence interval 1.40±5.11)
(Table III). After adjustment for age, skin color, and occupational
sun exposure by use of a multivariate model, the odds ratio was
3.40 (95% con®dence interval, 1.77±6.53). No such association was
found among women, who had a crude odds ratio related to the
presence of solar keratoses of 1.36 (95% con®dence interval 0.81±
2.29) (Table III), which was reduced to 1.03 (95% con®dence
interval 0.59±1.77) after adjustment for age, skin color, and
occupational sun exposure by use of a multivariate analysis.
Although individuals participating in this study were randomly
selected from a much larger skin cancer prevention trial involving
randomization to sunscreen and/or b-carotene (Green et al, 1994,
1999), adjustment for these interventions had no effect on the
association between solar keratoses and HPV infection (data not
shown).
DISCUSSION
In the Nambour population (Queensland, Australia), the presence
of EV±HPV DNA in plucked eyebrow hair was clearly associated
with the presence of solar keratoses. Age was strongly associated
with both the presence of EV±HPV infection in eyebrow hair and
solar keratoses. This study data con®rm these associations. We
speculate that individuals are gradually persistently infected with a
large range of cutaneous HPV types during their lifetime.
Nevertheless, increasing age only partly explains the association
between HPV infection and solar keratoses (see Table III).
Surprisingly, the association between HPV infection and solar
keratoses was observed among men but not women. An intriguing
question is why. As the overall EV±HPV prevalence in men and
women is similar, other factors than HPV infection per se may be
important for this difference between the genders. The higher level
of occupational sun exposure and smoking among men did not
explain this apparent difference. Thus, if this sex-speci®c association
is con®rmed in this study or by others, new sex-speci®c factors
(such as androgens) will need to be identi®ed that can explain the
difference between men and women regarding the association
between EV±HPV infection and solar keratoses.
The pathogenesis of solar keratoses and the subsequent squamous
cell carcinomas is a complex interplay between immunologic,
genetic, environmental, and possibly hormonal factors. The
observed association between solar keratoses, EV±HPV infection
and age might indicate that elderly patients not only more
frequently develop solar keratoses but also have a less effective
immunologic response against EV±HPV infections. On the other
hand in addition to sun exposure, EV±HPV infection may play a
direct part in the pathogenesis of solar keratoses. Sun exposure
might directly activate functions of the viral genes (Purdie et al,
1999) or sun-exposure may enhance HPV replication in the host by
inducing (local) immunosuppression and/or inactivation of kera-
tinocyte growth regulating host genes (e.g., p53) (Brash et al, 1991).
Recently, it was found that the E6 early protein from a range of
cutaneous HPV types (including the EV±HPV type 5) effectively
inhibits apoptosis by abrogation of Bak in response to ultraviolet
damage, which might be important for malignant progression of
HPV-containing lesions (Jackson and Storey, 2000; Jackson et al,
2000). As EV±HPV is widely distributed, as shown in the present
Table III. Risk of solar keratoses dependent on the presence of HPV DNA in plucked eyebrow hair strati®ed according to
age groups
Persons without
solar keratoses
n (%)
Persons with
solar keratoses
n (%) Odds ratio
Pooled
odds ratioa
Men
All ages HPV neg. 65 (71.4) 59 (38.3) 1 1
HPV pos. 26 (28.6) 95 (61.7) 4.03 (2.22; 7.33) 2.65 (1.40; 5.11)
25±39 y HPV neg. 29 (85.3) 8 (53.3) 1
HPV pos. 5 (14.7) 7 (46.7) 5.07 (1.05; 25.97)
40±59 y HPV neg. 32 (68.1) 35 (47.3) 1
HPV pos. 15 (31.9) 39 (52.7) 2.38 (1.04; 5.50)
60±79 y HPV neg. 4 (40.0) 16 (25.0) 1
HPV pos. 6 (60.0) 49 (75.0) 2.04 (0.42; 9.74)
Women
All ages HPV neg. 83 (59.3) 63 (51.6) 1 1
HPV pos. 57 (40.7) 59 (48.4) 1.36 (0.81; 2.29) 1.11 (0.63; 1.94)
25±39 y HPV neg. 22 (67.7) 4 (57.1) 1
HPV pos. 11 (33.4) 3 (42.9) 1.50 (0.21; 10.22)
40±59 y HPV neg. 49 (60.5) 37 (60.7) 1
HPV pos. 32 (39.5) 24 (39.3) 0.99 (0.48; 2.07)
60±79 y HPV neg. 12 (46.2) 22 (40.7) 1
HPV pos. 14 (53.8) 32 (59.3) 1.25 (0.44; 3.55)
aAdjustment for age groups, using Mantel±Haenszel weighted odds ratio.
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and other studies (Boxman et al, 1997, 1999), we hypothesize that
individuals who are infected by EV±HPV are at an increased risk of
developing solar keratoses and squamous cell carcinomas, possibly
by preventing ultraviolet-induced apoptosis.
Molecular biologic studies are required to clarify the mechanisms
by which the interplay between EV±HPV genes, ultraviolet
exposure, and keratinocyte cell growth and differentiation takes
place.
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